Jun 14, 2026 10:00AM
Jun 14, 2026 10:00AM
Jun 3, 2026 06:00AM
May 18, 2026 11:30AM
May 18, 2026 11:30AM
May 14, 2026 06:57AM
May 13, 2026 07:00AM Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
Apr 2, 2026 04:28PM
Mar 26, 2026 07:01AM
Mar 26, 2026 07:00AM
Mar 1, 2026 09:45AM
Mar 1, 2026 09:45AM
Feb 26, 2026 07:00AM
Feb 26, 2026 07:00AM Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Feb 11, 2026 06:00AM
Feb 11, 2026 06:00AM
Feb 11, 2026 06:00AM
Dec 22, 2025 07:06AM
Nov 5, 2025 07:00AM
Sep 30, 2025 05:01AM
Sep 30, 2025 04:15AM Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress
Sep 2, 2025 06:00AM
Sep 2, 2025 06:00AM
Aug 6, 2025 07:00AM
Jul 8, 2025 07:07AM
Jul 8, 2025 07:00AM
Jun 15, 2025 07:45AM
Jun 5, 2025 07:00AM Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025
May 20, 2025 07:01AM
May 20, 2025 07:00AM
May 6, 2025 07:00AM
Mar 12, 2025 07:00AM
Dec 17, 2024 08:00AM
Dec 16, 2024 08:00AM
Nov 7, 2024 07:00AM Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All